DocuSign, Inc. DOCU
Composite 57/100; the shares have moved about 51% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 41/100 — a slight mark against it.
Balance-sheet strength ranks 77/100 — a strong point in its favour. Quality ranks 60/100 — a slight point in its favour. Valuation ranks 52/100 — a slight point in its favour.
Growth ranks 41/100 — a slight mark against it. Momentum ranks 48/100 — a slight mark against it.
What the company does DocuSign provides an AI-powered intelligent agreement management platform, including e-signature, contract lifecycle management (CLM), document generation, and specialized solutions like real estate eSignature and remote online notarization.
Key financials Revenue grew 9% with 17% EPS growth on 80% gross margins and 10% net margins. ROE 16% and ROCE 19% reflect solid capital efficiency, while debt/equity of 0.10 supports financial flexibility.
Stock health Momentum is weak: -32% over 12m and -37% from the 52w high; RSI 59 indicates neutral momentum. Quality and strength scores (62 and 79) are above average, but income and momentum lag.
Price vs fair value The stock trades at a **discount** of 131.20% versus our fair-value estimate and a **discount** of 9.28% versus the 12-month target. - Trading down 7% in one day amid mixed sector sentiment (Zacks, 2026-07-30) - Simply Wall St flags potential 3% undervaluation post-earnings setup (Simply Wall St., 2026-07-30) - Recent articles highlight volatility despite broader software stock rallies (Zacks, StockStory, 2026-07-29/27)
Looking forward Forward P/E of 11x and PEG of 0.06 suggest valuation support, but revenue growth of 9% trails some peers. Analysts (n=18) see 16% upside to $59, balancing cautious near-term sentiment with long-term opportunity.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.